SCHEMBL6132033

SCHEMBL6132033

Cc1cccc(-c2[nH]nc(N)c2-c2ccccc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70
RPS6KA3 P51812 1/20 0.59
KMT2A Q03164 2/20 0.58
AKT2 P31751 1/20 0.58
PIK3CD O00329 1/20 0.55
PIK3CA P42336 1/20 0.55
PIK3CB P42338 1/20 0.55
PIK3CG P48736 1/20 0.55
PRKDC P78527 1/20 0.55
CYP3A4 P08684 1/20 0.48
IKBKB O14920 3/20 0.47
IKBKE Q14164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 2/20 0.45
ILK Q13418 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132022 0.84 MAPK1 (0.80) MAPK1NPSR1RPS6KA3KMT2AAKT2
SCHEMBL5820038 0.83 MAPK1 (1.00) MAPK1NPSR1RPS6KA3KMT2AAKT2
SCHEMBL8035063 0.82 PIK3CD (0.58) MAPK1NPSR1KMT2AAKT2PIK3CD
SCHEMBL6132021 0.81 MAPK1 (0.70) MAPK1NPSR1RPS6KA3KMT2AAKT2
SCHEMBL20247801 0.77 PIK3CD (0.56) KMT2APIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL6132032 0.76 MAPK1 (0.67) MAPK1NPSR1RPS6KA3KMT2AAKT2
SCHEMBL6132051 0.76 MAPK1 (0.83) MAPK1NPSR1RPS6KA3KMT2AAKT2
SCHEMBL6132090 0.75 MAPK1 (0.70) MAPK1NPSR1RPS6KA3KMT2AAKT2
SCHEMBL544723 0.74 AKT2 (1.00) MAPK1NPSR1RPS6KA3KMT2AAKT2
SCHEMBL6132067 0.74 MAPK1 (0.80) MAPK1NPSR1RPS6KA3KMT2AAKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP disclosed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP disclosed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed